AkzoNobel and ICCO fund child AIDS projects

Published: 1-Feb-2005


AkzoNobel and the ICCO (the Dutch Inter-Church Organisation for Development Co-operation) have signed a co-operation agreement to support two HIV/AIDS projects in the Johannesburg area of South Africa.

It puts the official seal on a partnership that began when the ICCO helped AkzoNobel to organise a support project in South Africa, designed to distribute the proceeds of a charity initiative involving the company's employees in the Netherlands.

The Sabelani Life Skills Project, which provides information on HIV/AIDS prevention, and the Lambano Baby Sanctuary, which provides homes for orphaned children with HIV/AIDS, will receive funding after AkzoNobel Nederlands's 'Cycling for Fun(d)' initiative raised more than e26,500 - which the ICCO doubled to €53,000 - by sponsoring employees for every kilometre cycled to work between October 2003 and October 2004.

'The partnership enables optimal use to be made of our expertise and network,' said Jack van Ham, general director of ICCO. 'ICCO has decided to double Akzo Nobel's donation because we value the initiative and because it fits in fully with our ambitions.'

See more

You may also like

Manufacturing

Improving healthcare has led to a higher salt requirement

Read more
The number of dialysis treatments is increasing across the globe, mainly due to an increasing number of patients and improved healthcare in many developing countries

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Improving healthcare has led to a higher salt requirement

The number of dialysis treatments is increasing across the globe, mainly due to an increasing number of patients and improved healthcare in many developing countries
Training & Education

AkzoNobel helps develop next generation of skilled workers

The company's commitment to inspiring young minds will be recognised in the Employer of the Year category of the inaugural Industrial Cadets Awards
Media

Schering-Plough acquisition of Organon BioSciences gets European Commission approval

<p>Schering-Plough Corporation has received approval from the European Commission for its planned acquisition of Organon BioSciences from Akzo Nobel as announced in March.</p>

Consortium to develop a pandemic flu vaccine

<p>A consortium of experts in the field of human virus research and vaccine development have joined forces to develop a novel pandemic influenza vaccine as a potential mergency vaccination. </p>
Sustainability

Xceleron and Organon sign microdose study agreement

<p>UK company Xceleron has signed a collaboration agreement with Organon, the human healthcare business unit of Akzo Nobel, on a three-compound human microdose study focusing on candidate selection for further clinical development. </p>
Sustainability

Organon and MRC Technology sign antibody development agreement

<p>Organon, the human healthcare business unit of Akzo Nobel, together with MRC Technology, of London in the UK, have signed a collaborative agreement to develop a humanised antibody for the treatment of certain forms of cancer. </p>
Sustainability

Organon and Dyax enter into therapeutic antibody alliance

<p>Organon, the human healthcare business unit of Akzo Nobel, has entered into an agreement with Dyax Corp. to discover and develop human therapeutic antibodies for the treatment of auto-immune diseases and cancer. </p>
Subscribe now